Drug
Ciclopirox
Ciclopirox is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Completed1
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
completed133%
withdrawn133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
NCT00382330
terminatedphase_4
Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children
NCT01646580
completedphase_4
Topical Penlac Nail Lacquer for Onychomycosis in Children
NCT01419847
Clinical Trials (3)
Showing 3 of 3 trials
NCT00382330Not Applicable
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
NCT01646580Phase 4
Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children
NCT01419847Phase 4
Topical Penlac Nail Lacquer for Onychomycosis in Children
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3